Introduction: Understanding the Perinatal SUD Continuum

Substance use disorder (SUD) during pregnancy remains a major public health challenge globally. While universal screening is a standard recommendation, clinicians often struggle to convert a positive screen into meaningful clinical outcomes. Recent data highlights significant attrition within the perinatal SUD continuum of care, emphasizing that screening is only the first step in a complex journey toward recovery.

National Data on Screening and Treatment Gaps

A recent study utilizing data from the 2021 to 2023 National Survey on Drug Use and Health examined patterns among over two million pregnant women. The results showed that nearly 65% of pregnant women underwent screening for substance use. However, while 14.3% met the diagnostic criteria for a past-year SUD, a mere 10% of those individuals actually engaged in treatment. This finding reveals a staggering gap between identification and care delivery.

The Power of Communication in the Perinatal SUD Continuum

The research discovered a pivotal factor for improving engagement: the provider's active role. Interestingly, screening alone did not increase the likelihood of a patient receiving treatment. Conversely, when healthcare professionals initiated direct conversations about treatment options or substance use, the odds of treatment engagement increased more than 10-fold. This suggests that the clinical interaction following screening is the most critical juncture in the perinatal SUD continuum.

Barriers to Care and Health Equity

Substantial disparities persist across various sociodemographic groups. Factors such as race, ethnicity, income, and criminal justice involvement significantly influence both the rates of screening and the prevalence of SUD. Furthermore, geographic location and insurance type play roles in how many women fall through the cracks of the healthcare system. To address these inequities, clinicians must adopt integrated obstetric-behavioral health models that prioritize patient-centered communication and care coordination.

Conclusion

Identifying substance use during pregnancy is insufficient if it does not lead to effective intervention. Strengthening the perinatal SUD continuum requires moving beyond checkboxes and focusing on proactive provider-led discussions. By reducing stigma and ensuring timely follow-up, medical professionals can significantly improve maternal health outcomes and foster equity across the board.

Frequently Asked Questions

1. Why does screening alone not improve treatment rates in the perinatal SUD continuum?

Screening identifies the problem but does not address the barriers to seeking help, such as fear of legal consequences or lack of resource awareness. Without a provider-initiated referral or a supportive conversation about treatment options, patients are unlikely to navigate the complex behavioral health system on their own.

2. How can clinicians increase treatment engagement for pregnant patients with SUD?

Clinicians should utilize "warm handoffs" and prioritize nonjudgmental communication. Actively discussing specific treatment options and coordinating care between obstetrics and psychiatry can increase the odds of treatment engagement by over 10 times compared to screening alone.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Healthcare providers should exercise their professional judgment and refer to the latest local and national guidelines for clinical practice.

References

1. Lombardi BN et al. Continuum of Care for Substance Use Disorders in Pregnancy: Evidence From the National Survey on Drug Use and Health. Subst Use Addctn J. 2026 May 19. doi: 10.1177/29767342261442453. PMID: 42157053.

2. American College of Obstetricians and Gynecologists (ACOG). Opioid Use and Opioid Use Disorder in Pregnancy. Committee Opinion No. 711. Obstet Gynecol. 2017;130(2):e81-e94.

3. World Health Organization. Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy. Geneva: World Health Organization; 2014.